THESE are the four major signs of a common condition which is likely to be triggered by cold weather – and when you should ...
The Bangkok Post on MSN
Overcoming that temptation to light up
A Malaysian survivor of chronic obstructive pulmonary disease (COPD) has shared his experience of his decades-long struggle ...
The place we thought we’d spend the rest of our lives is now a testing ground for someone else’s profit margins. The town calls it progress. Guest column by Robert ...
Delhi's air quality has plunged into a life-threatening emergency, exceeding 'severe' levels due to open fires, vehicles, and garbage burning, not jus ...
Researchers at Northwestern Medicine found that 65% of their lung cancer patients weren't eligible for screening. They were ...
This Comment is an urgent global call to action. I, as a pulmonologist, have concerns regarding the impacts of environmental ...
AstraZeneca’s Alexion division has received FDA approval for Koselugo (selumetinib) to treat adults with NF1 who have symptomatic, inoperable plexiform neurofibromas. The decision is based on strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback